JENNIFER JONES: Open Payments
NPI 1902916935 · SPOKANE, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$903 in 11 payments from 10 companies in 2025. Trend: 2023 $1,140 · 2024 $659 · 2025 $903
Food & beverage: $903
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 2 | $142 |
| Gilead Sciences, Inc. | 1 | $135 |
| Novo Nordisk Inc | 1 | $125 |
| SANOFI-AVENTIS U.S. LLC | 1 | $125 |
| Abbott Laboratories | 1 | $112 |
| Ascendis Pharma Endocrinology Inc | 1 | $81 |
| Sequel Med Tech, LLC | 1 | $72 |
| Medtronic, Inc. | 1 | $67 |
| PFIZER INC. | 1 | $27 |
| Corcept Therapeutics | 1 | $17 |
Products named: Ozempic, TZIELD, ZEPBOUND, FREESTYLE LIBRE 3, TWIIST, MINIMED 780G, ELIQUIS, MOUNJARO.
Industry payments across WA — which companies pay providers there.
